Postdoctoral fellow and co-first author Dongyoon Kim demonstrates some of the equipment used to craft the new ionizable lipids. The most common side effects of mRNA vaccines like the COVID-19 shot are ...

Actia Group recorded a 2025 revenue of 535.4 million euros, a slight increase of 0.1% from 2024 (535.1 million). This performance falls within the high end of the target range set by the group, ...

In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as pivotal players, offering new avenues for understanding the fine-tuned ...

Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, according to a study published in Science Advances. Shana Kelley, PhD, the ...

The Bolt EV and Bolt EUV battery fire risk saga continues with yet another safety recall. Back in 2020, dealers were required to install monitoring software for early ...

Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced the acquisition of the ACTIA (Autologous ...

State Key Laboratory of Separation Membrane and Membrane Process, School of Chemistry & School of Electronic and Information Engineering, Tiangong University, Tianjin 300387, P. R. China ...

As the years wear down on us, our bodies accumulate a whole host of damaged cells that stubbornly refuse to die. Called senescent cells, these cellular oddballs are like the moldy fruit in the basket, ...